Home / CLPBF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does CLPBF make money? Does CLPBF have pricing power? What's the Earnings Whisper? Will CLPBF profit more as the business scales? What is CLPBF's management track record? Is CLPBF's current price justified?

Coloplast A/S

$68.33 -$15.37 (-18.36%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$68.33

Day Range

$65.16$68.33

Year Range

$56.81$98.58

Market Cap

14.17B

AVG Volume

1.35K

Trailing/Forward PE

33.94/2.57

PEG ratio

9.05

Dividend Yield

5.53%

Next Earnings Date

2026-11-03

Primary Exchange

Other OTC

Revenue (DKK)

CLPBF Revenue (DKK) by quarter
Period	Revenue (DKK)
26 Q3	7.33B
26 Q2	7.09B
26 Q1	7.04B
25 Q4	6.95B
25 Q3	6.96B
25 Q2	6.93B
25 Q1	7.03B
24 Q4	6.95B
24 Q3	6.88B
24 Q2	6.59B

Net Income (DKK)

CLPBF Net Income (DKK) by quarter
Period	Net Income (DKK)
26 Q3	1.46B
26 Q2	-972.01M
26 Q1	1.4B
25 Q4	873.34M
25 Q3	805M
25 Q2	912M
25 Q1	1.04B
24 Q4	1.31B
24 Q3	1.27B
24 Q2	1.25B

Operating Income (DKK)

CLPBF Operating Income (DKK) by quarter
Period	Operating Income (DKK)
26 Q3	1.9B
26 Q2	1.8B
26 Q1	1.85B
25 Q4	1.92B
25 Q3	1.83B
25 Q2	1.89B
25 Q1	1.91B
24 Q4	1.91B
24 Q3	1.83B
24 Q2	1.79B

EBITDA (DKK)

CLPBF EBITDA (DKK) by quarter
Period	EBITDA (DKK)
26 Q3	2.26B
26 Q2	5.15B
26 Q1	2.18B
25 Q4	2.17B
25 Q3	2.17B
25 Q2	2.15B
25 Q1	2.3B
24 Q4	2.13B
24 Q3	2.2B
24 Q2	2.13B

Cash Flows (DKK)

CLPBF Cash Flows (DKK) by quarter
Period	Cash Flows (DKK)
26 Q3	1.44B
26 Q2	1.06B
26 Q1	1.86B
25 Q4	1.89B
25 Q3	1.21B
25 Q2	432M
25 Q1	1.7B
24 Q4	1.6B
24 Q3	1.14B
24 Q2	-2.83B

EPS (DKK)

CLPBF EPS (DKK) by quarter
Period	EPS (DKK)
26 Q3	6.47
26 Q2	-4.31
26 Q1	6.2
25 Q4	3.88
25 Q3	3.57
25 Q2	4.05
25 Q1	4.63
24 Q4	5.84
24 Q3	5.66
24 Q2	5.57

Expenses (DKK)

CLPBF Expenses (DKK) by quarter
Period	Expenses (DKK)
26 Q3	3.25B
26 Q2	3.32B
26 Q1	3.26B
25 Q4	3.2B
25 Q3	3.23B
25 Q2	3.17B
25 Q1	3.15B
24 Q4	3.24B
24 Q3	3.14B
24 Q2	2.97B

Cash & Debt (DKK)

CLPBF Cash & Debt (DKK) by quarter
Period	Cash & Debt (DKK)
26 Q3	814.09M
26 Q2	1.07B
26 Q1	1.12B
25 Q4	945.2M
25 Q3	726M
25 Q2	729M
25 Q1	906M
24 Q4	788M
24 Q3	887M
24 Q2	889M

Debt ratios

CLPBF Debt ratios by quarter
Period	Debt ratios
26 Q3	1.95
26 Q2	1.98
26 Q1	2.76
25 Q4	2.46
25 Q3	2.68
25 Q2	2.68
25 Q1	2.72
24 Q4	2.57
24 Q3	2.23
24 Q2	2.89

Margins

CLPBF Margins by quarter
Period	Margins
26 Q3	66.73%
26 Q2	42.95%
26 Q1	67.23%
25 Q4	68.42%
25 Q3	67.62%
25 Q2	68.23%
25 Q1	67.61%
24 Q4	66.73%
24 Q3	67.51%
24 Q2	67.98%

Return on Capital

CLPBF Return on Capital by quarter
Period	Return on Capital
26 Q3	10.94%
26 Q2	-7.56%
26 Q1	10.12%
25 Q4	5.43%
25 Q3	4.89%
25 Q2	5.38%
25 Q1	6.75%
24 Q4	7.32%
24 Q3	7.71%
24 Q2	7.73%

Shares Outstanding

CLPBF Shares Outstanding by quarter
Period	Shares Outstanding
26 Q3	225.37M
26 Q2	225.37M
26 Q1	225M
25 Q4	225.37M
25 Q3	225.4M
25 Q2	225.4M
25 Q1	225.3M
24 Q4	225M
24 Q3	225.09M
24 Q2	224.78M

Dividends (DKK)

CLPBF Dividends (DKK) by quarter
Period	Dividends (DKK)
May 26	0.78
Dec 25	2.8
May 25	0.76
Dec 24	2.41
May 24	0.72
Dec 23	2.32
May 23	0.73
Dec 22	2.12
May 22	0.71
Dec 21	2.13

Book Value Per Share (DKK)

CLPBF Book Value Per Share (DKK) by quarter
Period	Book Value Per Share (DKK)
26 Q3	59.1
26 Q2	57.05
26 Q1	61.35
25 Q4	71.4
25 Q3	72.97
25 Q2	75.16
25 Q1	68.62
24 Q4	79.74
24 Q3	73.41
24 Q2	72.07

Total Assets (DKK)

CLPBF Total Assets (DKK) by quarter
Period	Total Assets (DKK)
26 Q3	46.77B
26 Q2	46.7B
26 Q1	48.8B
25 Q4	48.27B
25 Q3	47.88B
25 Q2	49.15B
25 Q1	48.34B
24 Q4	48.07B
24 Q3	48.58B
24 Q2	48.14B

PE Ratio

CLPBF PE Ratio by quarter
Period	PE Ratio
Sep 26	47.18
Sep 26	47.12
Aug 26	47.25
Aug 26	46.87
Aug 26	45.01
Aug 26	45.25
Jul 26	46.28
Jul 26	45.08
Jul 26	42.06
Jul 26	43.33
Jul 26	42.36
Jun 26	21.27
Jun 26	20.98
Jun 26	21.81
Jun 26	21.1
May 26	21.88
May 26	22.89
May 26	21.9
May 26	23.3
May 26	23.11
Apr 26	23.93
Apr 26	24.67
Apr 26	23.49
Apr 26	24.29
Mar 26	26.76
Mar 26	26.83
Mar 26	28.39
Mar 26	28.02
Feb 26	30.2
Feb 26	29.79
Feb 26	29.57
Feb 26	31.36
Jan 26	32.6
Jan 26	32.97
Jan 26	35.88
Jan 26	35.11
Jan 26	33.08
Dec 25	29.38
Dec 25	30.18
Dec 25	31.09
Dec 25	32.29
Nov 25	32.19
Nov 25	32.43
Nov 25	33.92
Nov 25	33.63
Oct 25	32.4
Oct 25	32.06
Oct 25	30.57
Oct 25	30.4
Oct 25	30.08
Sep 25	27.23
Sep 25	29.08
Sep 25	31.1
Sep 25	30.59
Aug 25	30.67
Aug 25	30.9
Aug 25	29.91
Aug 25	29.45
Aug 25	29.58
Jul 25	30.24
Jul 25	30.22
Jul 25	29.52
Jul 25	28.51
Jun 25	26.6
Jun 25	27.05
Jun 25	29.78
Jun 25	28.36
May 25	29.48
May 25	29.04
May 25	30.53
May 25	30.3
May 25	31.75
Apr 25	32.22
Apr 25	29.89
Apr 25	29.9
Apr 25	31.26
Mar 25	31.96
Mar 25	32.56
Mar 25	32.07
Mar 25	32
Feb 25	34.94
Feb 25	34.32
Feb 25	35.15
Feb 25	35.36
Jan 25	36.28
Jan 25	35.26
Jan 25	36.02
Jan 25	34.32
Jan 25	33.99
Dec 24	35.37
Dec 24	36.47
Dec 24	36.21
Dec 24	38.76
Nov 24	41.08
Nov 24	39.24
Nov 24	39.96
Nov 24	40.99
Nov 24	40.44
Oct 24	39.53
Oct 24	40.47

Free Cash Flow Yield

CLPBF Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	6.07%
Sep 26	6.08%
Aug 26	6.06%
Aug 26	6.11%
Aug 26	6.37%
Aug 26	6.33%
Jul 26	6.19%
Jul 26	6.35%
Jul 26	6.81%
Jul 26	6.61%
Jul 26	6.76%
Jun 26	6.36%
Jun 26	6.45%
Jun 26	6.2%
Jun 26	6.41%
May 26	6.19%
May 26	5.91%
May 26	6.18%
May 26	5.81%
May 26	5.85%
Apr 26	5.65%
Apr 26	5.48%
Apr 26	5.76%
Apr 26	5.57%
Mar 26	5.38%
Mar 26	5.37%
Mar 26	5.08%
Mar 26	5.14%
Feb 26	4.77%
Feb 26	4.84%
Feb 26	4.87%
Feb 26	4.6%
Jan 26	4.42%
Jan 26	4.37%
Jan 26	4.02%
Jan 26	4.1%
Jan 26	4.36%
Dec 25	4.13%
Dec 25	4.02%
Dec 25	3.9%
Dec 25	3.76%
Nov 25	3.77%
Nov 25	3.74%
Nov 25	3.58%
Nov 25	3.61%
Oct 25	3.75%
Oct 25	3.79%
Oct 25	3.97%
Oct 25	3.99%
Oct 25	4.04%
Sep 25	3.94%
Sep 25	3.69%
Sep 25	3.45%
Sep 25	3.51%
Aug 25	3.5%
Aug 25	3.47%
Aug 25	3.59%
Aug 25	3.64%
Aug 25	3.63%
Jul 25	3.55%
Jul 25	3.55%
Jul 25	3.63%
Jul 25	3.76%
Jun 25	1.24%
Jun 25	1.22%
Jun 25	1.1%
Jun 25	1.16%
May 25	1.12%
May 25	1.13%
May 25	1.08%
May 25	1.09%
May 25	1.04%
Apr 25	1.02%
Apr 25	1.1%
Apr 25	1.1%
Apr 25	1.05%
Mar 25	0.88%
Mar 25	0.86%
Mar 25	0.88%
Mar 25	0.88%
Feb 25	0.8%
Feb 25	0.82%
Feb 25	0.8%
Feb 25	0.79%
Jan 25	0.77%
Jan 25	0.8%
Jan 25	0.78%
Jan 25	0.82%
Jan 25	0.83%
Dec 24	0.75%
Dec 24	0.72%
Dec 24	0.73%
Dec 24	0.68%
Nov 24	0.64%
Nov 24	0.67%
Nov 24	0.66%
Nov 24	0.64%
Nov 24	0.65%
Oct 24	0.67%
Oct 24	0.65%

Price to Sales

CLPBF Price to Sales by quarter
Period	Price to Sales
Sep 26	3.54
Sep 26	3.53
Aug 26	3.54
Aug 26	3.52
Aug 26	3.38
Aug 26	3.39
Jul 26	3.47
Jul 26	3.38
Jul 26	3.16
Jul 26	3.25
Jul 26	3.18
Jun 26	3.04
Jun 26	3
Jun 26	3.12
Jun 26	3.02
May 26	3.13
May 26	3.27
May 26	3.13
May 26	3.33
May 26	3.31
Apr 26	3.42
Apr 26	3.53
Apr 26	3.36
Apr 26	3.47
Mar 26	3.49
Mar 26	3.5
Mar 26	3.7
Mar 26	3.66
Feb 26	3.94
Feb 26	3.89
Feb 26	3.86
Feb 26	4.09
Jan 26	4.25
Jan 26	4.3
Jan 26	4.68
Jan 26	4.58
Jan 26	4.32
Dec 25	4.3
Dec 25	4.41
Dec 25	4.55
Dec 25	4.72
Nov 25	4.71
Nov 25	4.74
Nov 25	4.96
Nov 25	4.92
Oct 25	4.74
Oct 25	4.69
Oct 25	4.47
Oct 25	4.45
Oct 25	4.4
Sep 25	4.45
Sep 25	4.75
Sep 25	5.08
Sep 25	5
Aug 25	5.01
Aug 25	5.05
Aug 25	4.89
Aug 25	4.81
Aug 25	4.84
Jul 25	4.94
Jul 25	4.94
Jul 25	4.83
Jul 25	4.66
Jun 25	4.73
Jun 25	4.81
Jun 25	5.3
Jun 25	5.05
May 25	5.25
May 25	5.17
May 25	5.43
May 25	5.39
May 25	5.65
Apr 25	5.73
Apr 25	5.32
Apr 25	5.32
Apr 25	5.56
Mar 25	5.97
Mar 25	6.09
Mar 25	5.99
Mar 25	5.98
Feb 25	6.53
Feb 25	6.41
Feb 25	6.57
Feb 25	6.61
Jan 25	6.78
Jan 25	6.59
Jan 25	6.73
Jan 25	6.41
Jan 25	6.35
Dec 24	6.68
Dec 24	6.89
Dec 24	6.84
Dec 24	7.32
Nov 24	7.76
Nov 24	7.41
Nov 24	7.55
Nov 24	7.74
Nov 24	7.64
Oct 24	7.46
Oct 24	7.64

EV/EBITDA

CLPBF EV/EBITDA by quarter
Period	EV/EBITDA
Sep 26	10.48
Sep 26	10.47
Aug 26	10.49
Aug 26	10.42
Aug 26	10.09
Aug 26	10.13
Jul 26	10.32
Jul 26	10.1
Jul 26	9.56
Jul 26	9.79
Jul 26	9.61
Jun 26	12.53
Jun 26	12.4
Jun 26	12.78
Jun 26	12.45
May 26	12.81
May 26	13.27
May 26	12.82
May 26	13.46
May 26	13.37
Apr 26	13.75
Apr 26	14.09
Apr 26	13.55
Apr 26	13.92
Mar 26	13.51
Mar 26	13.54
Mar 26	14.19
Mar 26	14.03
Feb 26	14.93
Feb 26	14.76
Feb 26	14.67
Feb 26	15.41
Jan 26	15.92
Jan 26	16.08
Jan 26	17.28
Jan 26	16.96
Jan 26	16.12
Dec 25	16.35
Dec 25	16.73
Dec 25	17.15
Dec 25	17.7
Nov 25	17.66
Nov 25	17.77
Nov 25	18.46
Nov 25	18.33
Oct 25	17.76
Oct 25	17.6
Oct 25	16.91
Oct 25	16.83
Oct 25	16.68
Sep 25	16.77
Sep 25	17.73
Sep 25	18.77
Sep 25	18.51
Aug 25	18.55
Aug 25	18.67
Aug 25	18.16
Aug 25	17.92
Aug 25	17.99
Jul 25	18.33
Jul 25	18.32
Jul 25	17.96
Jul 25	17.43
Jun 25	17.56
Jun 25	17.81
Jun 25	19.33
Jun 25	18.54
May 25	19.17
May 25	18.92
May 25	19.75
May 25	19.63
May 25	20.43
Apr 25	20.69
Apr 25	19.39
Apr 25	19.4
Apr 25	20.16
Mar 25	21.58
Mar 25	21.94
Mar 25	21.65
Mar 25	21.61
Feb 25	23.36
Feb 25	22.99
Feb 25	23.48
Feb 25	23.61
Jan 25	24.15
Jan 25	23.55
Jan 25	24
Jan 25	22.99
Jan 25	22.79
Dec 24	23.27
Dec 24	23.92
Dec 24	23.77
Dec 24	25.28
Nov 24	26.66
Nov 24	25.57
Nov 24	26
Nov 24	26.61
Nov 24	26.28
Oct 24	25.74
Oct 24	26.3

Price/Operating Cashflow

CLPBF Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 26	13.08
Sep 26	13.06
Aug 26	13.1
Aug 26	12.99
Aug 26	12.48
Aug 26	12.54
Jul 26	12.83
Jul 26	12.5
Jul 26	11.66
Jul 26	12.01
Jul 26	11.74
Jun 26	12.36
Jun 26	12.19
Jun 26	12.67
Jun 26	12.26
May 26	12.71
May 26	13.3
May 26	12.73
May 26	13.54
May 26	13.43
Apr 26	13.91
Apr 26	14.34
Apr 26	13.65
Apr 26	14.12
Mar 26	14.65
Mar 26	14.68
Mar 26	15.54
Mar 26	15.34
Feb 26	16.53
Feb 26	16.3
Feb 26	16.18
Feb 26	17.16
Jan 26	17.84
Jan 26	18.04
Jan 26	19.63
Jan 26	19.21
Jan 26	18.1
Dec 25	18.62
Dec 25	19.13
Dec 25	19.71
Dec 25	20.47
Nov 25	20.41
Nov 25	20.56
Nov 25	21.5
Nov 25	21.32
Oct 25	20.54
Oct 25	20.32
Oct 25	19.38
Oct 25	19.27
Oct 25	19.07
Sep 25	19.68
Sep 25	21.02
Sep 25	22.48
Sep 25	22.11
Aug 25	22.17
Aug 25	22.34
Aug 25	21.62
Aug 25	21.28
Aug 25	21.38
Jul 25	21.85
Jul 25	21.84
Jul 25	21.34
Jul 25	20.61
Jun 25	43.51
Jun 25	44.25
Jun 25	48.72
Jun 25	46.4
May 25	48.24
May 25	47.51
May 25	49.95
May 25	49.58
May 25	51.95
Apr 25	52.72
Apr 25	48.9
Apr 25	48.92
Apr 25	51.14
Mar 25	58.37
Mar 25	59.47
Mar 25	58.58
Mar 25	58.44
Feb 25	63.81
Feb 25	62.69
Feb 25	64.2
Feb 25	64.58
Jan 25	66.26
Jan 25	64.4
Jan 25	65.8
Jan 25	62.68
Jan 25	62.09
Dec 24	67.6
Dec 24	69.7
Dec 24	69.21
Dec 24	74.07
Nov 24	78.51
Nov 24	74.99
Nov 24	76.37
Nov 24	78.33
Nov 24	77.28
Oct 24	75.54
Oct 24	77.35

Price to Book

CLPBF Price to Book by quarter
Period	Price to Book
Sep 26	7.72
Sep 26	7.71
Aug 26	7.73
Aug 26	7.67
Aug 26	7.36
Aug 26	7.4
Jul 26	7.57
Jul 26	7.38
Jul 26	6.88
Jul 26	7.09
Jul 26	6.93
Jun 26	6.14
Jun 26	6.06
Jun 26	6.3
Jun 26	6.09
May 26	6.32
May 26	6.61
May 26	6.33
May 26	6.73
May 26	6.68
Apr 26	6.91
Apr 26	7.13
Apr 26	6.78
Apr 26	7.02
Mar 26	6.04
Mar 26	6.06
Mar 26	6.41
Mar 26	6.33
Feb 26	6.82
Feb 26	6.73
Feb 26	6.68
Feb 26	7.08
Jan 26	7.36
Jan 26	7.45
Jan 26	8.1
Jan 26	7.93
Jan 26	7.47
Dec 25	7.28
Dec 25	7.48
Dec 25	7.7
Dec 25	8
Nov 25	7.98
Nov 25	8.04
Nov 25	8.4
Nov 25	8.33
Oct 25	8.03
Oct 25	7.94
Oct 25	7.57
Oct 25	7.53
Oct 25	7.45
Sep 25	7.3
Sep 25	7.8
Sep 25	8.34
Sep 25	8.2
Aug 25	8.23
Aug 25	8.29
Aug 25	8.02
Aug 25	7.9
Aug 25	7.93
Jul 25	8.11
Jul 25	8.11
Jul 25	7.92
Jul 25	7.65
Jun 25	8.4
Jun 25	8.54
Jun 25	9.41
Jun 25	8.96
May 25	9.31
May 25	9.17
May 25	9.64
May 25	9.57
May 25	10.03
Apr 25	10.18
Apr 25	9.44
Apr 25	9.44
Apr 25	9.87
Mar 25	9
Mar 25	9.17
Mar 25	9.03
Mar 25	9.01
Feb 25	9.84
Feb 25	9.66
Feb 25	9.9
Feb 25	9.96
Jan 25	10.21
Jan 25	9.93
Jan 25	10.14
Jan 25	9.66
Jan 25	9.57
Dec 24	10.63
Dec 24	10.96
Dec 24	10.89
Dec 24	11.65
Nov 24	12.35
Nov 24	11.79
Nov 24	12.01
Nov 24	12.32
Nov 24	12.15
Oct 24	11.88
Oct 24	12.17

No video analysis for this stock yet. Request one from our team.

News: CLPBF

reuters.com · 18 Aug 2026

Coloplast expects Kerecis wound-care unit to return to growth in 2027, CFO says

Medical equipment maker Coloplast expects its Kerecis wound-care business to return to growth from January 2027 after changes to U.S. Medicare payments caused sales in outpatient settings to fall sharply, its finance chief ‌told Reuters on Tuesday.

seekingalpha.com · 5 Aug 2026

Coloplast Might Have Found Its Bottom

Coloplast remains a 'Buy,' trading ~20% below intrinsic value despite recent struggles and special charges. Organic growth was 6% in Q2-25/26, but reported results were impacted by a DKK 3 billion Kerecis impairment and currency headwinds. Management guides for 5–6% organic revenue growth and 5% EBIT growth in FY25/26, but targets 7–8% annual organic growth and 20%+ ROIC by FY29/30.

AI Analysis

Coloplast A/S

Video analysis: CLPBF

News: CLPBF

Coloplast expects Kerecis wound-care unit to return to growth in 2027, CFO says

Coloplast Might Have Found Its Bottom

Similar companies